These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 5710998)
1. Studies on the mode of action of sea urchin toxin. II. Enzymatic and immunological behavior. Feigen GA; Sanz E; Tomita JT; Alender CB Toxicon; 1968 Aug; 6(1):17-43. PubMed ID: 5710998 [No Abstract] [Full Text] [Related]
2. Studies on the mode of action of sea urchin toxin. I. Conditions affecting release of hiamine and other agents from isolated tissues. Feigen GA; Sanz E; Alender CB Toxicon; 1966 Nov; 4(3):161-75. PubMed ID: 6005006 [No Abstract] [Full Text] [Related]
3. Mechanism of action of purified scorpion toxin on the isolated rat intestine. Melo JR; Freire-Maia L; Tafuri WL; Maria TA Toxicon; 1973 Jan; 11(1):81-4. PubMed ID: 4725562 [No Abstract] [Full Text] [Related]
5. Multiple mechanisms of bradykinin-induced contraction in rat and guinea pig smooth muscles in vitro. Calixto JB Eur J Pharmacol; 1995 Aug; 281(3):279-88. PubMed ID: 8521911 [TBL] [Abstract][Full Text] [Related]
6. The action of toxins derived from scorpion venom on the ileal smooth muscle preparation. Tintpulver M; Zerachia T; Zlotkin E Toxicon; 1976 Aug; 14(5):371-7. PubMed ID: 982477 [No Abstract] [Full Text] [Related]
7. Structural elements of anaphylatoxin obtained by contact activation of hog serum. Liefländer M; Dielenberg D; Schmidt G; Vogi W Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):385-92. PubMed ID: 5028204 [No Abstract] [Full Text] [Related]
8. Some effects of staphylococcal alpha-toxin on isolated mammalian smooth muscle preparations. Brown DA; Quilliam JP Br J Pharmacol Chemother; 1965 Dec; 25(3):781-9. PubMed ID: 4380601 [No Abstract] [Full Text] [Related]
9. The presence of a smooth muscle contracting and bradykinin potentiating factor in plasma. Louhija A; Sipilä R Biochem Pharmacol; 1972 Apr; 21(8):1151-8. PubMed ID: 5034199 [No Abstract] [Full Text] [Related]
10. Bradykinin-potentiating activity in human serum. Araujo RL; Gomez MV; da Silva WD; Vieira MN Agents Actions; 1973 Dec; 3(5):275-7. PubMed ID: 4785025 [No Abstract] [Full Text] [Related]
11. Recent studies on the mode of action of scorpion neurotoxins. A review. Zlotkin E; Shulov AS Toxicon; 1969 Nov; 7(3):217-21. PubMed ID: 4311543 [No Abstract] [Full Text] [Related]
12. [The effect of potentiating factors on the bradykinine effect in vitro]. Paegelow I; Reissmann S; Arold H Acta Biol Med Ger; 1976; 35(2):235-44. PubMed ID: 1033653 [TBL] [Abstract][Full Text] [Related]
13. The purification of a kininogen from human plasma. Brocklehurst WE; Mawer GE Br J Pharmacol Chemother; 1966 Aug; 27(2):256-76. PubMed ID: 5967365 [No Abstract] [Full Text] [Related]
14. Bypass-activation of the complement system starting with C3. II. C3-activation by gamma-1-immune aggregates in guinea pig serum. König W; Bitter-Suermann D; Dierich M; Hadding U Immunochemistry; 1973 Jul; 10(7):431-7. PubMed ID: 4125109 [No Abstract] [Full Text] [Related]
15. Some immunological aspects of sea nettle toxins. Burnett JW; Goldner R Toxicon; 1971 Jul; 9(3):271-7. PubMed ID: 4397519 [No Abstract] [Full Text] [Related]